Clinical Trial Update: S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating S-1 plus nedaplatin with concurrent radiotherapy for advanced esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Nedaplatin (nedaplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Cancer | Phase 1 | Status: COMPLETED